HDFC Life Insurance Company on Thursday reported a 15% year-on-year (YoY) rise in its Q4FY25 net profit to Rs 475 crore, compared to Rs 411 crore in the year-ago period. Net premium income for the quarter ended March stood at Rs 23,842 crore, up 16% YoY from Rs 20,533 crore in the corresponding quarter of the previous financial year.
The company's board also recommended a final dividend of Rs 2.10 per equity share for the financial year 2024–25.
The company attributed its topline growth to strong individual APE growth of 18%, supported by an increase in both the number of policies sold and average ticket size, along with a balanced product mix.
HDFC Life's Assets Under Management (AUM) stood at Rs 3,36,282 crore as of March 31, 2025, reflecting a 15% year-on-year increase.
Market Share
The company’s overall market share (individual WRP) rose by 70 basis points to 11.1% for the period 11MFY25, according to the company filing. The private sector market share increased by 30 basis points to 15.7%.
Solvency Ratio
The solvency ratio stood at 194%, comfortably above the regulatory threshold of 150%.
Profit After Tax (PAT) for the full financial year stood at Rs 1,802 crore, reflecting a 15% year-on-year growth, supported by an 18% increase in profit emergence from the company’s back book.
Management Commentary
Commenting on the earnings, MD & CEO Vibha Padalkar described FY25 as a year in which the company deepened its reach.
“We are happy to report an 18% growth in Individual APE for FY25, in line with our stated growth aspirations for the year. Our overall industry market share expanded by 70 basis points to 11.1%, and by 30 basis points to 15.7% within the private sector. Retail protection continued to show strong momentum with APE growth of 25%. All channels registered double-digit growth. We continue to enhance customer experience through intuitive digital platforms, with over 90% of service requests now handled via self-service,” she said.
Value of New Business (VNB)
VNB grew by 13% to Rs 3,962 crore in FY25.
Persistency
The 13th-month and 61st-month persistency ratios stood at a strong 87% and 63%, respectively. Notably, the 61st-month persistency improved by 1,000 basis points, reflecting the company’s deep customer engagement and effective retention initiatives.
The company's board also recommended a final dividend of Rs 2.10 per equity share for the financial year 2024–25.
The company attributed its topline growth to strong individual APE growth of 18%, supported by an increase in both the number of policies sold and average ticket size, along with a balanced product mix.
HDFC Life's Assets Under Management (AUM) stood at Rs 3,36,282 crore as of March 31, 2025, reflecting a 15% year-on-year increase.
Market Share
The company’s overall market share (individual WRP) rose by 70 basis points to 11.1% for the period 11MFY25, according to the company filing. The private sector market share increased by 30 basis points to 15.7%.
Solvency Ratio
The solvency ratio stood at 194%, comfortably above the regulatory threshold of 150%.
Profit After Tax (PAT) for the full financial year stood at Rs 1,802 crore, reflecting a 15% year-on-year growth, supported by an 18% increase in profit emergence from the company’s back book.
Management Commentary
Commenting on the earnings, MD & CEO Vibha Padalkar described FY25 as a year in which the company deepened its reach.
“We are happy to report an 18% growth in Individual APE for FY25, in line with our stated growth aspirations for the year. Our overall industry market share expanded by 70 basis points to 11.1%, and by 30 basis points to 15.7% within the private sector. Retail protection continued to show strong momentum with APE growth of 25%. All channels registered double-digit growth. We continue to enhance customer experience through intuitive digital platforms, with over 90% of service requests now handled via self-service,” she said.
Value of New Business (VNB)
VNB grew by 13% to Rs 3,962 crore in FY25.
Persistency
The 13th-month and 61st-month persistency ratios stood at a strong 87% and 63%, respectively. Notably, the 61st-month persistency improved by 1,000 basis points, reflecting the company’s deep customer engagement and effective retention initiatives.
You may also like
Global Biopharma IPOs Surge 68% To $8.52 Billion In 2024, Highest Total Raised Since 2021
'I tried Treatwell and it made booking hair and nail treatments a breeze'
Modi's 'Vocal for Local' reflects at NIFT's Craft Bazaar: Darshana Jardosh
Iran, US begin second round of nuclear talks in Rome amid high regional tensions
Win Couple Match Tickets & Gift Vouchers with Trends Footwear's Exciting 'Power Play' Contest!
